Lorbriqua (Lorlatinib Tablet) 100mg

Lorbriqua (lorlatinib) 100mg tablets are prescribed for certain types of non-small cell lung cancer. This oral medication belongs to the ALK inhibitor class and is taken once daily. Store at room temperature in a dry place. Always follow your healthcare provider’s instructions.

Strength

100mg

Pack Size

30s

Storage

Ambient

Manufacturer / TM Owner

Pfizer

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Lorbriqua (lorlatinib) 100mg tablets are used to treat adults with anaplastic lymphoma kinase-positive (ALK+) metastatic non-small cell lung cancer. It is designed for patients whose cancer has progressed on other ALK inhibitors. This medication works by blocking signals that cause cancer cells to grow. It is not a cure but may help control disease progression.

Side Effects

Lorbriqua (lorlatinib) 100mg tablets may help reduce symptoms such as coughing or shortness of breath related to lung cancer. Some patients report improved energy levels during treatment. Common effects include mild nausea, fatigue, or changes in mood. These effects vary by individual and should be discussed with a healthcare professional.

Precautions & Warnings

Keep Lorbriqua (lorlatinib) 100mg tablets in their original packaging and out of reach of children. Store at room temperature away from moisture and heat. Do not use if the seal is broken or the tablets appear damaged. Inform your doctor about all medications and supplements you are taking before starting this treatment.

Avoid Interactions

Lorbriqua (lorlatinib) 100mg tablets may interact with strong CYP3A inhibitors or inducers, which can affect how the drug works. Avoid grapefruit products while taking this medication. Alcohol use should be discussed with your doctor. Certain supplements, such as St. John’s wort, may also interact and should be avoided.

Frequently Asked Questions

Lorbriqua (lorlatinib) 100mg tablets are used to treat ALK-positive metastatic non-small cell lung cancer in adults.

Store Lorbriqua 100mg tablets at room temperature in a dry place, away from moisture and heat.

Tell your doctor about all medications and supplements you take, as some may interact with Lorbriqua.

If you miss a dose, take it as soon as you remember unless it’s almost time for the next dose. Do not double up on doses.

Common effects may include mild nausea, fatigue, or mood changes. Discuss any concerns with your healthcare provider.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.